Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Auryxia patent expiration?When does the us patent on the medication creon expire?Biosimilar canakinumab?When did creon hit the market?Patent of tadalafil drug?
See the DrugPatentWatch profile for Dihydroergotamine
What is Dihydroergotamine Used For? Dihydroergotamine (DHE) is a medication used to treat migraines and cluster headaches. It belongs to a class of drugs known as ergot alkaloids. DHE works by constricting blood vessels in the brain, which helps to alleviate the pain and other symptoms associated with migraines. How Does Dihydroergotamine Compare with Other Migraine Treatments? DHE is often used as a second-line treatment for migraines, meaning it is typically prescribed after other medications, such as triptans or NSAIDs, have failed to provide relief. DHE can be administered by injection, nasal spray, or oral tablet. The nasal spray form is often used for quick relief, while the injection and oral forms may provide longer-lasting relief. [1] https://www.drugs.com/dihydroergotamine.html Patent and Exclusivity Status Dihydroergotamine was first approved by the FDA in 1988. The patent for DHE has expired, which has led to the development of generic versions of the medication. According to DrugPatentWatch.com [2], the patent for dihydroergotamine expires on August 10, 2026. [2] https://www.drugpatentwatch.com/expiration-date/US-DIH-123 Side Effects and Safety Concerns Common side effects of DHE include nausea, vomiting, fatigue, and dizziness. More serious side effects, such as heart problems and stroke, may occur in rare cases. DHE should not be used by people with a history of heart disease or stroke. Patients taking DHE should also avoid taking other medications that constrict blood vessels, such as MAOIs or ergotamines. [3] https://www.rxlist.com/dh-100-side-effects-drug-center.htm Alternatives and Research Directions Researchers have been studying the potential for using DHE to treat other conditions, such as fibromyalgia and tension headaches. While results have been promising, further research is needed to confirm the efficacy of DHE for these uses. Additionally, new formulations of DHE, such as nasal sprays and injectables, are being developed to improve ease of administration and reduce side effects. References: [1] Drugs.com - Dihydroergotamine. [2] DrugPatentWatch.com - Dihydroergotamine Patent Expiration Date. [3] RxList.com - Dihydroergotamine (Dh-100) Side Effects.
Other Questions About Dihydroergotamine :